France (FR)

The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods (2017) Landi F, Cesari M, Calvani R, Cherubini A, Di Bari M, Bejuit R, Mshid J, et al. Journal article Scale-dependent diffusion anisotropy in nanoporous silicon. (2017) Kondrashova D, Lauerer A, Mehlhorn D, Jobic H, Feldhoff A, Thommes M, Chakraborty D, et al. Journal article, Original article Opening the Cages of Faujasite-Type Zeolite. (2017) Qin Z, Cychosz KA, Melinte G, El Siblani H, Gilson JP, Thommes M, Fernandez C, et al. Journal article, Original article Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4 (2017) Buzzoni R, Carnaghi C, Strosberg J, Fazio N, Singh S, Herbst F, Ridolfi A, et al. Journal article The attitudes of medical students in Europe toward the clinical importance of histology (2017) Moxham BJ, Emmanouil-Nikoloussi E, Brenner E, Plaisant O, Brichova H, Kucera T, Pais D, et al. Journal article Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide autogel/depot 120mg in the CLARINET open-label extension (2017) Cwikla JB, Wolin EM, Pavel ME, Phan AT, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution Age calibration of the Lower Ordovician Fezouata Lagerstätte (Morocco) (2017) Lefebvre B, Lehnert O, Gutiérrez-Marco JC, Martin ELO, Nowak H, Akodad M, El Hariri K, Servais T Journal article PREDICTION OF PROGRESSIVE SKIN THICKENING IN EARLY DIFFUSE SYSTEMIC SCLEROSIS USING THREE-MONTHLY SKIN SCORES FROM THE EUROPEAN SCLERODERMA OBSERVATIONAL STUDY (ESOS) (2017) Herrick A, Peytrignet S, Pan X, Hesselstrand R, Mouthon L, Brown E, Czirjak L, et al. Conference contribution OPEN-LABEL, MULTICENTER, DOSE-ESCALATING PHASE II CLINICAL TRIAL ON THE SAFETY AND EFFICACY OF TADEKINIG ALPHA IN ADULT ONSET STILL'S DISEASE (2017) Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Koetter I, Hachulla E, et al. Conference contribution APREMILAST TREATMENT AND LONG-TERM (UP TO 156 WEEKS) IMPROVEMENTS IN DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF A LARGE DATABASE OF THE PHASE III CLINICAL DEVELOPMENT PROGRAM (2017) Gladman DD, Kavanaugh A, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, et al. Conference contribution